Open AccessMetabolic Effects of Empagliflozin in Heart Failure: A Randomized, Double-Blind, and Placebo-Controlled Trial (Empire HF Metabolic)
Author(s) -
J. Steen Jensen,
Massar Omar,
Caroline Kistorp,
Christian Tuxen,
Finn Gustafsson,
Lars Køber,
Jens Faber,
Julie Lyng Forman,
Jacob Eifer Møller,
Morten Schou
Publication year - 2021
Publication title -
circulation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 7.795
H-Index - 607
eISSN - 1524-4539
pISSN - 0009-7322
DOI - 10.1161/circulationaha.120.053463
Subject(s) - empagliflozin , medicine , heart failure , placebo , randomized controlled trial , double blind , placebo controlled study , cardiology , pharmacology , diabetes mellitus , endocrinology , type 2 diabetes , alternative medicine , pathology
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom